Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study

Egyptian Journal of Medical Human Genetics

Table 3 Liver functions in AML and ALL patients and control group

Liver function	Control (n = 40)	AML (n = 40)	ALL (n = 40)	Test of sig.	p
SGOT (U/l)
Range	21.0–35.0	9.0–100.0	15.0–100.0	H = 7.444*	0.024*
Mean ± SE	28.20 ± 1.10	39.04 ± 4.31	48.21 ± 5.73
Median	28.50	37.50	50.00
Sig. bet. grps	p₁ = 0.101, p₂ = 0.007*, p₃ = 0.188
SGPT(U/l)
Range	10.0–19.0	5.0–130.0	30.0–110.0	H = 33.282*	< 0.001*
Mean ± SE	15.30 ± 0.83	46.07 ± 6.03	53.34 ± 4.73
Median	17.50	39.00	49.00
Sig. bet. grps	p₁ < 0.001, p₂ < 0.001, p₃ = 0.102
Alb (mg/dl)
Range	3.60–4.70	2.40–4.90	2.50–4.90	F = 5.632*	0.006*
Mean ± SE.	4.31 ± 0.07	3.83 ± 0.13	3.64 ± 0.19
Median	4.40	3.80	3.60
Sig. bet. grps	p₁ = 0.024, p₂ = 0.007, p₃ = 0.485

H, p, H and p values for Kruskal-Wallis test. Pairwise comparison bet. each of the 2 groups was done using post hoc test (Dunn’s for multiple comparisons test). F, p, F and p values for ANOVA test. Pairwise comparison bet. each of the 2 groups was done using post hoc test (LSD). p₁, p value for comparing between control group and AML group; p₂, p value for comparing between control group and ALL group; and p₃, p value for comparing between AML group and ALL group
*Statistically significant at p ≤ 0.05